Tetrathiomolybdate mediates cisplatin-induced p38 signaling and EGFR degradation and enhances response to cisplatin therapy in gynecologic cancers
Kyu Kwang Kim(Brown University), Richard G. Moore(University of Rochester Medical Center)
Cited by 22
Related Papers
Tetrathiomolybdate inhibits mitochondrial complex IV and mediates degradation of hypoxia-inducible factor-1α in cancer cells
|Scientific Reports|2015|62
Tetrathiomolybdate sensitizes ovarian cancer cells to anticancer drugs doxorubicin, fenretinide, 5-fluorouracil and mitomycin C
|BMC Cancer|2012|40
Role of trypsin and protease-activated receptor-2 in ovarian cancer
|PLoS ONE|2020|40
Efficacy of a Non-Hypercalcemic Vitamin-D2 Derived Anti-Cancer Agent (MT19c) and Inhibition of Fatty Acid Synthesis in an Ovarian Cancer Xenograft Model
|PLoS ONE|2012|20
Development of Potent Forchlorfenuron Analogs and Their Cytotoxic Effect in Cancer Cell Lines
|Scientific Reports|2020|20